SCHEMBL5960458

SCHEMBL5960458

O=C(O)c1c(O)cc(/C=C/c2ccccc2)cc1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.58
HNF4A P41235 1/20 0.58
SLC5A1 P13866 1/20 0.56
SLC5A2 P31639 1/20 0.56
AHR P35869 1/20 0.55
PTPN6 P29350 2/20 0.51
TTR P02766 2/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50
CA14 Q9ULX7 1/20 0.50
ALOX5 P09917 1/20 0.50
PTGS1 P23219 1/20 0.50
PTGS2 P35354 1/20 0.50
P2RX3 P56373 1/20 0.49
CYP19A1 P11511 1/20 0.49
CYP2C9 P11712 1/20 0.49
MAOA P21397 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5960459 1.00 PTPN1 (0.58) PTPN1HNF4ASLC5A1SLC5A2AHR
SCHEMBL19420358 0.86 PTGS1 (0.58) PTPN1PTPN6TTRCA12CA1
SCHEMBL25522549 0.85 AHR (0.56) PTPN1HNF4ASLC5A1SLC5A2AHR
SCHEMBL19420484 0.82 LCK (0.65) PTPN1HNF4APTPN6TTRCA12
SCHEMBL6229522 0.80 SLC5A1 (0.61) PTPN1HNF4ASLC5A1SLC5A2TTR
SCHEMBL5960451 0.80 CA12 (0.56) PTPN1SLC5A1SLC5A2AHRTTR
SCHEMBL6229519 0.80 SLC5A1 (0.61) PTPN1HNF4ASLC5A1SLC5A2TTR
SCHEMBL30358577 0.80 SLC5A1 (0.61) PTPN1HNF4ASLC5A1SLC5A2TTR
SCHEMBL5960447 0.80 CA12 (0.56) PTPN1SLC5A1SLC5A2AHRTTR
SCHEMBL10597010 0.79 PTPN1 (0.71) PTPN1HNF4AAHRPTPN6TTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006004722-A2 COMPOSITIONS AND METHODS FOR SELECTIVELY ACTIVATING HUMAN SIRTUINS BIOMOL RESEARCH LABORATORIES, INC. (US) 2006-01-12 WO claimed
US-11253455-B2 Carboxylated polyphenol derivatives and their cosmetic use L'ORÉAL (FR) 2022-02-22 US disclosed
US-11058619-B2 Carboxylated polyphenol derivatives and their cosmetic use L'ORÉAL (FR) 2021-07-13 US disclosed
US-20200197275-A1 CARBOXYLATED POLYPHENOL DERIVATIVES AND THEIR COSMETIC USE L'OREAL (FR) 2020-06-25 US disclosed
US-20190151215-A1 CARBOXYLATED POLYPHENOL DERIVATIVES AND THEIR COSMETIC USE L'ORÉAL (FR) 2019-05-23 US disclosed
WO-2006004722-A2 COMPOSITIONS AND METHODS FOR SELECTIVELY ACTIVATING HUMAN SIRTUINS BIOMOL RESEARCH LABORATORIES, INC. (US) 2006-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190151215-A1 CARBOXYLATED POLYPHENOL DERIVATIVES AND THEIR COSMETIC USE H1-0, GLA, NQO1 PTPN1 4781/4885HNF4A 3616/4885SLC5A1 4396/4885
US-20200197275-A1 CARBOXYLATED POLYPHENOL DERIVATIVES AND THEIR COSMETIC USE H1-0, GLA, NQO1 PTPN1 4754/4885HNF4A 3303/4885SLC5A1 4088/4885
US-11253455-B2 Carboxylated polyphenol derivatives and their cosmetic use H1-0, GLA, NQO1 PTPN1 4781/4885HNF4A 3616/4885SLC5A1 4396/4885
US-11058619-B2 Carboxylated polyphenol derivatives and their cosmetic use H1-0, GLA, NQO1 PTPN1 4754/4885HNF4A 3303/4885SLC5A1 4088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.